Loydie A. Jerome-Majewska
Professor, Department of Pediatrics, Division of Endocrinology and Metabolism
PhD
- BA, Biology, Honors, Wesleyan University, Middletown, CT, USA, 1991-1995
- MA/MPhil, Developmental Biology, The Integrated Program of Cellular Molecular Biophysics, Columbia University, New York, NY, USA, 1995-1998
- PhD with Distinction, Developmental Biology, The Integrated Program of Cellular Molecular Biophysics, Columbia University, New York, NY, USA, 1998-2001
- Postdoctoral Fellowship, Department of Biology and Genetics, Columbia University, New York, NY, USA, 2001-2003Ìý
- Postdoctoral Fellowship, Department of Embryology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 2003-2005Ìý
Dr. Loydie Jerome-Majewska uses the mouse to study the genetic and cellular basis of morphogenesis during the embryonic period in her research program. Goals of her research program are to identify genes responsible for congenital malformations that increase morbidity and mortality in newborns. Next Generation sequencing and gene engineering are used to help to explain the etiology and pathophysiology of several syndromes including: 22q11.2 deletion syndrome, Cednik syndrome and the spliceosomopathies: CCMS, MFDM and Nager syndrome. Current goals are to identify factors which can be used to prevent/reduce morbidity associated with congenital malformations associated with mutations in the spliceosome.
- Mouse Genetics
- Embryology
- Protein Transport
- Splicing
Ìý
- Congenital malformations
- 22q11.2 deletion syndrome
- Cednik syndrome
- Acrofacial Dysostosis
- Mandibulofacial syndrome with microcephaly (MFDM)
- Nager/Rodriguez Syndrome
- Cerebrocostomandibular syndrome
Ìý
- Recognized for “Excellence in Canadian Research-Association for Anatomy, Neurobiology-American Association of Anatomistsâ€, 2011
- Haile T. Debas Prize, Faculty of Medicine, Ï㽶ÊÓƵ, 2014
- Ï㽶ÊÓƵ Equity Award, Faculty of Medicine, Ï㽶ÊÓƵ, 2022
- Marylou Buyse Excellence in Craniofacial Research Award, SCGDB Society, 2022